Murine colonic adenomas induced by the loss of a single copy of the tumor suppressor gene Apc in Lrig1 +/-expressing progenitor cells grow rapidly, with high penetrance and tumor multiplicity. This study investigates the prevalence of intertumoral genetic heterogeneity and phenotypic variation across tumors, and attempts to identify the genomic cause of the unusual phenotype. Adult Lrig1-CreERT2/+; Apc-flox/+ mice were intraperitoneal injected with 2mg tamoxifen for 3 consecutive days which induced highly penetrant, dysplastic adenomas in the distal colon ~100 days later. Whole tumors (n=14) from 8 mice were excised and tumor exome DNA and mRNA were sequenced. Somatic mutations present in the tumor exome DNA were compared with adjacent normal colon (n=9 tumors from 3 mice). Putative somatic mutations were called after stringent filtering using SeuratSomatic, a Genome Analysis Toolkit software module. RNA-Seq was performed on tumor mRNA (n=5 tumors from 5 mice) compared to wildtype colon (n=3). Differential gene expression was profiled using the R package DESeq2. Copy number variations and splicing defects were assessed using custom tracks on the UCSC genome browser.
Introduction
Human colorectal cancer (CRC) is the second leading cause of cancer death in the US, and ~25% of CRC patients are incurable at the time of diagnosis 1, 2 . CRC rates are sharply increasing in younger patients, who tend to be diagnosed at an advanced stage when there are few effective targeted therapies available to treat the disease. Genetic heterogeneity is inherent to the disease, providing tumor cells with the ability to rapidly adapt and resist treatments 3, 4 . Currently CRC is clinically segregated into four broad subcategories based on the expression of various biomarker molecules called consensus molecular subtypes, however this classification system greatly oversimplifies the diversity and interrelatedness of cancer cell species 5 . Recent breakthroughs in 'tumor-omics' research have revealed countless genes and growth mechanisms involved in regulating tumor pathology, but lists of biomarkers and knowledge about signaling pathways have not yet translated into substantial disease cures. The specific steps required to counteract the critical aspects of CRC progression remain very poorly understood despite decades of research.
The difficulty in treating CRC is due to the inevitable unpredictability of natural selection, which enables cancer cells to behave as moving targets to evade treatment through constant evolution.
Tumors often acquire resistance to cancer therapies by accumulating slight alterations in immune signaling, metabolic status, and ectopic gene expression via the accumulation of de novo somatic mutations, and the existence of several subtypes of CRC further complicates treatment since each subtype presents its own unique set of challenges.
The cell-of-origin of CRC derives from a population of rapidly-dividing colonic stem cells located at the base of the intestinal epithelial crypts, which are identifiable based on the expression of leucine-rich repeat containing G protein-coupled receptor 5 (Lgr5). Lgr5 is the downstream target of R-spondin in the canonical Wnt/ β-catenin pathway. Mutations in the tumor suppressor gene Adenomatous Polyposis Coli (Apc) and other members of the canonical Wnt pathway are the hallmark of CRC [6] [7] [8] [9] ; loss of heterozygosity (LOH) of Apc tends to occur during the early stages of CRC tumorigenesis and precipitates a cascade of deleterious effects which disrupt a cell's ability to regulate the cell cycle.
Human tumors often exhibit distinct patterns of somatic mutations based on the specific category of mutation and the background genomic sequence context of the damage [10] [11] [12] . These somatic signatures can vary greatly depending on the anatomical location and carcinogenic agents involved in a given tumor and can sometimes reveal sources of mutation. For example, tumors caused by tobacco tar contain an abundance of C > A transition point mutations due to the formation of guanine adducts. Our current understanding of the variation of somatic genomic landscapes across CRC cells and tumors within is a host is incomplete due to the highly heterogeneous nature of CRC 5 . Functional DNA mismatch repair enzymes are required for maintaining genomic integrity, but the specific signaling mechanisms involved in regulating these processes remain unresolved [13] [14] [15] [16] .
Leucine-rich repeats and immunoglobulin-like domains 1 (Lrig1) is a transmembrane feedback regulator of growth factor receptor tyrosine kinases that is expressed in the Lgr5 + stem cell population present at the base of the colonic crypts [17] [18] [19] [20] . Lrig1 acts as a tumor suppressor gene in several contexts [21] [22] [23] [24] [25] [26] This work seeks to understand the genomic changes occurring during the early stages of tumorigenesis in rapidly-growing Lrig1-(Apc-flox) murine colonic adenomas. Exomic DNA and mRNA captured from the Lrig1-(Apc-flox) adenomas was sequenced in order to detect the presence of transcriptomic and genomic alterations. Specifically, the genetic heterogeneity and somatic signatures of tumors from a single mouse were assessed using exome DNA profiling and the prevalence of differential gene expression and splicing defects was assessed across tumors using mRNA-Seq. The tumors are highly heterogeneous in terms of the specific genetic loci mutated, displaying high genetic variability across tumors. Each adenoma contained a unique profile of ~100 high-frequency and high-quality mutations predicted to cause significant functional disruptions based on amino acid conservation. Two genes were mutated in 4/9 tumors: Muc4 and Dhx8 (Table S1 ). Eleven genes were independently mutated in >30% of the tumors ( Figure S1 ).
Results

Adenomas
The 40 most commonly mutated genes (>20%) are predicted to impact cell morphology and migration based of pathway analysis, and are present in over 10% of human CRC cases in The
Cancer Genome Atlas (TCGA) database. Despite their highly variable genomes, the tumors exhibited substantial transcriptome similarity to each other ( Figure S3) . Downregulation of the DNA repair genes Msh3 and Msh4 and several UDP glucuronosyltransferases was detected ( Table S2) . Upregulation of Dkk was also observed, highlighting the fact that tumor biomarkers can vary according to the stage, location, and genetic context of the tumor. Tumors consistently displayed abnormal patterns of intron retention in several RNA-binding genes ( Figure S4 ). Compared to wildtype, the tumor transcripts display a loss of intron retention, which is a phenomenon sometimes observed in breast cancer 30 .
This observation suggests that modifications in post-transcriptional gene regulation are exploited
by the tumor cells in order to gain additional selective advantages against the host.
The proposed mechanism of colonic adenoma formation in the Lrig1-(Apc-flox) model is the following: Epigenetic loss of Apc leads to a decrease in goblet cells and a corresponding increase in inflammatory reactive oxygen species (ROS) 31 . Somatic mutations occur subsequently as a result of increased inflammation and provide the raw genetic material required for adenoma formation and progression. Natural selection of growth-promoting mutations leads to convergent evolution towards an invasive phenotype marked by invasion, increased survival, and alternate modes of Wnt pathway activation. The high incidence of adenomas in the distal colon can be explained by the higher prevalence of microbial-produced ROS localized to the distal colon and rectum.
Discussion
In this study, the exomes and transcriptomes of conditionally induced murine colonic adenomas from Lrig1-(Apc-flox) mice were examined to assess the incidence and of genomic Identifying somatic mutations from tumor genomic data is an inherently difficult and expensive technique due the high rate of false negative mutations and the inability of standard sequencing methods to detect low frequency alleles. The detection rate of false positive mutations in this study was significantly reduced with the use of high-stringency filtering steps. Matched nontumor samples are required to filter background germline variants from tumor genomic data, but even deep sequencing of a matched nontumor sample will not remove all false positive somatic mutations from a dataset. All animal and tumor genomic datasets have unique germline SNPs, repetitive, and noncoding regions that appear as somatic when using a standard reference genome for data alignment. The vast majority of these germline variants can be filtered out using the public dbSNP database, however a low level of germline SNPs will remain in due to dbSNP errors or insufficient coverage of that locus in the nontumor sample. Additional steps would be required to verify the somatic nature of mutations of interest, such as ultra-deep sequencing of the locus of original wild-type strain. The somatic mutations detected in this study are assumed real based on the clear signature of a pattern of C>A mutations, which is very unlikely to occur due to chance.
To further support of the validity of the detected mutations, this dataset was compared to control nontumor samples and mouse glioblastoma whole genome DNA sequencing datasets (n=3) and no clear mutational patterns were observed in the controls. Anecdotally, the detected mutations were clearly malignant in nature but not so completely destructive as to kill the mice. Due to the low sequencing depth employed in this study, the somatic mutations detected likely represent only a fraction of the actual number present in the tumors. 
Generation of Lrig1-driven colonic adenomas
Generation of Lrig1-CreERT2, Apcflox/+ tumors was performed by the Coffey lab as previously 
DNA read alignment and processing
Raw fastq reads were cleaned to remove low quality bases at the ends of the reads using Stacks (v 1.35) process_shortreads 33 . Cleaned reads were aligned to the mus musculus (house mouse) genome (2011 assembly, UCSC Genome Browser assembly ID mm10, Genome Reference Consortium Mouse Build 38, Accession GCA_000001635.2) using Bowtie2 (v2.2.1), in defaultsensitive mode 34 . Sam/bam files were sorted and indexed using SAMtools (v0.1.18) 35 and Picard Tools (v1.92) (Broad Institute, MIT License). Base quality score recalibration and indel realignment were performed according to GATK best practices 36 .
Mutation calling, filtering, and visualization
Somatic mutations were called using SeuratSomatic (v2.5), a GATK module [37] [38] [39] . Somatic variants were called using a minimum variant coverage of 4 reads and minimum quality score of Q10. To ensure that the identified mutations were somatic in nature, matched normal tissue samples were used to filter germline variants. Residual germline polymorphisms were removed by filtering all germline variants reported on NCBI's dbSNP database 40 . To reduce the occurrence of sequencing errors in the data, variants were called only if they were present in both the forward and reverse DNA strand 41 . To confirm that the discovered mutations were not due to alignment artifacts, the presence of representative variants was verified in the raw sequencing reads using grep and BLAST. The predicted effect of the mutations on protein function was determined with Ensembl's variant effect predictor (VEP) program 42 as well as the SnpEff variant annotation and effect prediction tool 43 . The somatic signature of the mutations was identified using the R package SomaticSignatures 39 . Genomic data was visualized using the R packages GenVisR and ggplot2 44, 45 Negative control nontumor samples and mouse glioblastoma whole genome DNA sequencing datasets (n=3, provided by Hui Zong Lab) were compared to this dataset.
RNA sequencing and analysis
Whole tumors (n=6) as well as normal wildtype colon (n=3), were excised and mRNA was sequenced to 25x average read depth. Cleaned cDNA reads were aligned to the mouse mm10 genome (Accession GCA_000001635.2) with STAR(v1.0). Changes in gene expression were identified using the R package DESeq2 and visualized with the R packages DESeq2, ggplot2, and
Pathview. Custom bigwig tracks were created on the UCSC Genome browser in order to assess copy number variations 46 . Figure S1 . Putative Driver Mutations in Lrig1-(Apc-flox) Colonic Adenomas. Supplementary Tables   Table S1 . Somatic mutations identified in Lrig1-Cre/+;Apcfl/+ colonic adenomas 
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